Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)

This study evaluates the possibility of Magnetic Resonance Imaging (MRI) based respiratory motion correction of simultaneously acquired cardiac Positron Emission Tomography (PET) images.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Imaging

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Maastricht University Hospital

Maastricht, Limburg, 6229HX, Netherlands

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18F-FDG injection for clinical diagnostic PET/MRI or PET/CT

Exclusion criteria

Diet-suppressed myocardial uptake of 18F-FDG
General exclusion criteria for MRI (i.e. metallic implants, claustrophobia, pregnancy, etc.)
Not willing to be informed about incidental findings

Treatment and study plan

Cardiac PET/MRI

Diagnostic Test

For patients undergoing 18-Fluor- fluorodeoxyglucose (18F-FDG) PET/MRI or PET/Computed Tomography (CT), additional cardiac PET/MRI scans are acquired.

Primary outcomes

Target-to-background ratio (TBR)

Time frame: 15-20 minutes

Secondary outcomes

Signal-to-noise ratio (SNR)

Time frame: 15-20 minutes

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Registry information

Important dates

Study start: 2017
Primary completion: 2021
Study completion: 2021
First posted: Jun 27, 2017
Registry last updated: Apr 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed